Results 151 to 160 of about 1,020 (190)

Deprescription as a tool of pharmaceutical care for the elderly

open access: yesRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2018
openaire   +1 more source
Some of the next articles are maybe not open access.

Related searches:

A prudent deprescription model

Medicina Clínica (English Edition), 2015
The therapeutic structure of health systems relies heavily on medical prescription, which generates a marked tendency to add drugs to a patient's medical history. There is an absence of incentives for professionals to reassess prescriptions and withdraw those with a negative or neutral risk/benefit.
Joaquín, Hortal Carmona   +2 more
openaire   +2 more sources

Deprescription in elderly patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice, 2020
The Primary aim is to verify physicians' adherence to the 2016 Italian diabetes guidelines therapeutic targets, and their habits on deprescription in elderly persons with Type 2 Diabetes Mellitus (T2DM). Secondary aims are the assessment of the potential impact of the targets' changes in 2018 Italian guidelines, and the outcomes of deprescription in ...
Silverii G. A.   +5 more
openaire   +2 more sources

Control Task Analysis of the Deprescription Process: A Pilot Study

Proceedings of the Human Factors and Ergonomics Society Annual Meeting, 2023
Deprescription is the process by which a physician supervises a patient’s withdrawal or dose reduction of a given medication due to side effects or diminishing efficacy. Prior studies on the process of deprescription have resulted in a number of models, two of which are used in this pilot study alongside the decision ladder to construct a novel ...
Connor Wurst   +7 more
openaire   +1 more source

Deprescription in Advanced Cancer Patients Referred to Palliative Care

Journal of Pain & Palliative Care Pharmacotherapy, 2016
In palliative care, drugs are considered futile if they do not have a short-term benefit in symptom control or quality of life. The authors examined pharmacotherapy prescribed for patients referred to palliative care to identify futile drugs. This was a retrospective analysis of patients referred over 6 months, focusing on the prescription of gastric ...
Liliana, Oliveira   +4 more
openaire   +2 more sources

Deprescription in elderly: A spotlight on pharmacoeconomic aspect

Clinical and Experimental Pharmacology and Physiology, 2019
AbstractAging is a complex process and many factors in the elderly, especially multiple diseases and related unnecessary drug use, support a deprescription approach to this age group to save money and health cost. In this review, we have searched for studies related to the pharmacoeconomic aspect of this deprescription approach in the elderly.
openaire   +2 more sources

125 A strategy for urinary incontinence treatment deprescription

Poster presentations, 2018
Objectives To evaluate the impact of a strategy for the optimization of the urinary incontinence treatment in patients with diapers. In aged patients, the use of drugs for urinary incontinence contributes to increase the risk of suffering adverse effects such as delirium, tachycardia, atrial fibrillation, dry mouth, falls, eye dryness or constipation.
Natalia Alzueta   +8 more
openaire   +1 more source

Deprescription in the Oncological Population

African Journal of Biomedical Research
Prescribing supportive care medications for cancer patients can present significant challenges for medical oncologists, particularly due to the occurrence of chemotherapy-induced ADRs. To enhance patient care, it is essential to evaluate and prioritize supportive medications based on potential drug-drug interactions.
Dr. Batoul Barari Tajani   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy